(2 years, 10 months ago)
Lords ChamberI thank the noble Lord for bringing that matter to my attention. He always has the most up-to-date news on these matters at his fingertips. I will ensure that that particular company is looked at by my officials.
My Lords, I declare an interest as the vice-chairman of the All-Party Parliamentary Group on Uyghurs. Has the Minister noted the all-party amendment passed in your Lordships’ House on Tuesday night, urging more concerted action in dealing with companies and countries banned in the jurisdictions of our closest allies and tainted by everything from genocide to slave labour? As the noble Lord, Lord Rooker, said, should we not stand in unity with our Five Eyes allies? Will we not stand with companies such as H&M, which has now been boycotted in China for refusing to use cotton from Xinjiang that is farmed by slaves, and make it clear whose side we are on—on the side of the slaves or on the side of the slave-drivers?
My Lords, we always bow to the noble Lord’s deep expertise in these matters, and we all very much appreciate the close attention that he pays to them. I like to think that the United Kingdom is one of the global leaders in bringing this issue to people’s attention. We have sponsored resolutions at the UN and elsewhere in relation to this, and will continue to do so.
(3 years, 9 months ago)
Lords ChamberTo ask Her Majesty’s Government what plans they have to use the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights to guarantee access to affordable drugs in (1) the United Kingdom, and (2) developing countries.
The Government have long supported affordable and equitable access to medicines, including in developing countries. We believe that a robust and fair intellectual property system is essential for an innovation framework. It allows economies to grow while enabling society to benefit from knowledge and ideas. The Government are therefore working within the TRIPS framework to collaborate with public and private partners, in the UK and internationally, to promote affordable access to medicines for all.
My Lords, in the context of hundreds of millions of Covid vaccines being held in the United Kingdom and the significant sums of public money invested in developing new drugs and treatments, notwithstanding the need to generate funds to enable future research and development, when companies such as Gilead repurpose drugs such as remdesivir and charge $2,340 for a Covid treatment that Liverpool University estimates can be made for $9, should the Government not invoke their powers to use Crown licences to prevent patent monopolies impeding access to medicine, to ensure equitable access, to prevent exploitative profiteering, and to recognise that affordable drugs and their fair distribution are a public good that this country should be at the forefront in providing?
My Lords, I think we all agree that the world urgently needs access for all to safe, effective, quality and affordable vaccines, diagnostic medicines and other health technologies to enable an effective response to the Covid-19 pandemic. Intellectual property rights provide incentives to create and commercialise new inventions such as life-changing vaccines. In short, they keep innovators innovating, creators creating and investors investing.
(3 years, 9 months ago)
Lords ChamberI thank the noble Earl for his comments about the Japan free trade agreement. Like other Members of this House, I am looking forward to our debate on it in a couple of weeks’ time. We are following the spirit—if not the letter—of the Command Paper to which he refers.
My Lords, in the House of Commons yesterday the Trade Minister, Greg Hands MP, said:
“We are negotiating better market access in markets such as ... China”.—[Official Report, Commons, 17/11/20; col. 196.]
Today Bob Rae, Canada’s ambassador to the United Nations, has called on the UN to investigate the horrors being perpetrated in Xinjiang. Some 180 human rights groups say that many of the world’s biggest fashion brands and retailers, along with suppliers of PPE to the United Kingdom, and companies such as Huawei and Volkswagen are complicit in the forced labour and human rights violations of millions of Uighur people in Xinjiang. Atrocities include torture, forced separation and the compulsory sterilisation of Uighur women. Is it a case of business as usual, or does the Minister believe that, where allegations of crimes against humanity or genocide are made, these should have consequences for trade with China? Will he therefore accept the amendment on genocide that I have tabled to the Trade Bill?
The noble Lord always speaks on this topic with both expertise and passion. We understand the importance that noble Lords attach to these matters. The Government are studying them actively and carefully.